The anti-tumour action of Cucurbitacin B was found to involve the activation of GSDMD-dependent pyroptosis of non-small cell lung cancer (NSCLC) cells in vitro and in vivo (Yuan et al., 2021). This evidence concerns the gene GSDMD and non-small cell lung carcinoma.